Suppr超能文献

抗抑郁药使用者新发糖尿病的风险——一项系统评价与荟萃分析。

The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysis.

作者信息

Salvi Virginio, Grua Ilaria, Cerveri Giancarlo, Mencacci Claudio, Barone-Adesi Francesco

机构信息

Department of Neuroscience, ASST Fatebenefratelli-Sacco, Milan, Italy.

Department of Pharmaceutical Sciences, University of Eastern Piedmont, Novara, Italy.

出版信息

PLoS One. 2017 Jul 31;12(7):e0182088. doi: 10.1371/journal.pone.0182088. eCollection 2017.

Abstract

BACKGROUND

Antidepressant Drugs (ADs) are among the most commonly prescribed medications in developed countries. The available epidemiological evidence suggests an association between AD use and higher risk of developing type 2 diabetes mellitus. However, some methodological issues make the interpretation of these results difficult. Moreover, very recent studies provided conflicting results. Given the high prevalence of both diabetes and AD use in many countries, clarifying whether this association is causal is of extreme relevance for the public health. The aim of the present study is to provide an up-to-date evaluation of the evidence in support of a causal role of ADs in inducing diabetes.

METHODS AND FINDINGS

A systematic literature search was conducted to identify relevant studies in MEDLINE (PubMed), PsycINFO, and International Pharmaceutical Abstracts (IPA) through 31st December 2016. Only studies assessing the incidence of new-onset diabetes in subjects treated with ADs were included. Results were pooled using a random-effects meta-analysis. Moreover, we extensively reviewed the role of the different sources of bias that have been proposed to explain the association between AD and diabetes. Twenty studies met the inclusion criteria. In the meta-analysis, the association between AD use and diabetes was still evident after the inclusion of the recent negative studies [pooled relative risk = 1.27, 95% confidence interval (CI), 1.19-1.35; p<0.001]. None of the biases proposed by previous authors seemed able to fully explain the observed association.

CONCLUSIONS

This updated meta-analysis confirms the association between AD use and incident diabetes. It still remains a matter of debate whether single ADs exert a different effect on the risk of diabetes. Given the possible heterogeneity, we suggest that a classification of ADs according to their pharmacological profiles could be useful in better elucidating the nature of this association.

摘要

背景

抗抑郁药物(ADs)是发达国家中最常开具的药物之一。现有的流行病学证据表明,使用ADs与患2型糖尿病的较高风险之间存在关联。然而,一些方法学问题使得对这些结果的解释变得困难。此外,最近的研究得出了相互矛盾的结果。鉴于许多国家糖尿病和ADs使用的高患病率,阐明这种关联是否具有因果关系对公共卫生极为重要。本研究的目的是对支持ADs在诱发糖尿病中起因果作用的证据进行最新评估。

方法与结果

通过检索MEDLINE(PubMed)、PsycINFO和国际药学文摘(IPA),对截至2016年12月31日的相关研究进行了系统的文献检索。仅纳入评估接受ADs治疗的受试者中新发糖尿病发病率的研究。使用随机效应荟萃分析对结果进行汇总。此外,我们广泛回顾了已提出的不同偏倚来源在解释AD与糖尿病之间关联中的作用。二十项研究符合纳入标准。在荟萃分析中,纳入最近的阴性研究后,ADs使用与糖尿病之间的关联仍然明显[合并相对风险 = 1.27,95%置信区间(CI),1.19 - 1.35;p < 0.001]。先前作者提出的偏倚似乎都无法完全解释观察到的关联。

结论

这项最新的荟萃分析证实了ADs使用与糖尿病发病之间的关联。单一ADs对糖尿病风险是否有不同影响仍存在争议。鉴于可能存在的异质性,我们建议根据其药理学特征对ADs进行分类可能有助于更好地阐明这种关联的性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/616a/5536271/f8a3df2ea7ba/pone.0182088.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验